Top Stories
The automated insulin delivery system was originally cleared for type 1 diabetes in 2024.
The tool developed by researchers at the University of Technology Sydney could support more personalised assessments and treatment.
OPKO had kept 4Kscore when it sold its BioReference oncology testing operations last year.
A research consortium will investigate how contactless hospital monitoring and at-home ECGs could be incorporated into routine cardiac care across Europe
The two funds will invest in biopharmas, medical device and diagnostic developers, and tech-forward healthcare service providers.
Conference News
Genio® bilateral stimulation delivered a 74.3% median reduction in AHI at 12 months, with no device- or procedure-related serious adverse eventsPMA supplement submitted to the FDA to expand Genio’s in...
LAS VEGAS, NV, UNITED STATES, October 15, 2026 /EINPresswire.com/ -- Dr. Lucian Feraru, Chief Medical Officer of WoundScribe, today unveiled the company's AI-powered wound care app at SAWC Fall 2026, ...
New approach to PCR-free whole genome sequencing debuts at ASHG 2026 as Early Access beginsBoulder, Colorado, US, 15th October 2026 /Sciad Communications/ Watchmaker Genomics today announced the intro...
Chief Medical Officer Gordon Downie, MD, to host CHEST 2026 Learning Theater on clinical use of CyPath® LungPresentation to address current challenges in pulmonary nodule management and to discuss pre...
NATICK, Mass., Oct. 15, 2026 /PRNewswire/ -- Pillar Biosciences today announced that ten scientific posters featuring their NGS technology will be presented, including a platform presentation at the 2...
